NEW YORK – A University of California at San Diego- and VA San Diego Healthcare System (VASDHS)-led team has used a volley of transcriptomic and antigen receptor sequencing strategies to characterize tissue and immune cell features in individuals with or without ulcerative colitis, a form of inflammatory bowel disease (IBD).